NICE Ltd.: Form 20-F for the period ended Dec 31, 2024
Filed with the SEC on Mar 19, 2025 and accepted by EDGAR at Mar 19, 2025, 16:43 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-01-01 to 2024-12-31 | $2.74bn | us-gaap:Revenues |
| Cost of revenue | 12 months2024-01-01 to 2024-12-31 | $909.5m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2024-01-01 to 2024-12-31 | $1.83bn | us-gaap:GrossProfit |
| Research and development | 12 months2024-01-01 to 2024-12-31 | $360.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2024-01-01 to 2024-12-31 | $546.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2024-01-01 to 2024-12-31 | $46.0k | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months2024-01-01 to 2024-12-31 | $162.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2024-01-01 to 2024-12-31 | $439.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2024-01-01 to 2024-12-31 | $6.76 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2024-01-01 to 2024-12-31 | $6.97 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2024-01-01 to 2024-12-31 | 65,506,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2024-01-01 to 2024-12-31 | $832.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2024-01-01 to 2024-12-31 | $35.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2024-01-01 to 2024-12-31 | $369.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-12-31 | $481.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-12-31 | $2.50bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $5.30bn | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $1.47bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2024-12-31 | $0 | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-12-31 | $458.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-12-31 | $3.59bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2024-12-31 | 63,249,843 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001003935-25-000004. Last ingested by Listed: Oct 29, 2026, 16:35 ET. Listed shows no prices and gives no investment advice.